CClinicalTrials.gg
CompletedNCT04409821CO-CarESUpdated Nov 18, 2023

Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care

An interventional study of Tele-delivered psychological intervention in Posttraumatic Stress Disorder, Prolonged Grief Disorder and COVID, sponsored by Rigshospitalet, Denmark. Completed at 6 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The experience of a loved one's stay in a COVID-19 intensive care unit (ICU), either intubated or on respiratory support, forces family caregivers (hereafter 'caregivers') to face core existential fears, such as uncertainty and death. It also poses a serious threat to basic human needs for autonomy, competence, and relatedness, as family caregivers have no control over the illness, and limited prior competence in dealing with critical illness. COVID-19 likely aggravates this experience, as social distancing cuts caregivers off from visiting patients in the ICU, from using their usual social supportive network and the threat of infection extends to caregivers themselves, their children and family. Combined, these extreme circumstances put caregivers in emotional turmoil and in need of psychological support and assistance in managing difficult emotions. ICU caregivers are at risk of developing clinically relevant symptoms of anxiety or posttraumatic stress. During the patient's ICU stay, caregivers experience peri-traumatic distress, such as helplessness, grief, frustration and anger, that may predict later posttraumatic stress disorder (PTSD). Symptoms of anxiety and PTSD may last for months to years after the patient's discharge. Further, caregivers of patients who die in an ICU may be at greater risk of prolonged grief disorder. Supportive interventions may reduce psychological late effects in ICU caregivers, but the primary focus of the majority of interventions has been on communication or surrogate decision making. The CO-CarES study aims to develop and test the feasibility of a tele-delivered psychological intervention to enable caregivers of ICU patients with COVID-19 to better endure the overwhelming uncertainty and emotional strain and reduce the risk of posttraumatic stress and prolonged grief. The study hypothesizes that providing psychological intervention during and after the patients' hospitalization, can decrease peri-traumatic distress during ICU hospitalization and decrease risk of post-traumatic stress, anxiety, depression and perceived stress following discharge, as well as prolonged grief in bereavement. A secondary hypothesis is that changes in emotion regulation mediate effects of the intervention on long-term psychological outcomes.

02

Conditions studied

  • Posttraumatic Stress Disorder
  • Prolonged Grief Disorder
  • COVID

Keywords

  • Informal caregiver
  • COVID-19
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 40 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • close relatives or friends of a patient hospitalized in an intensive care or intermediary care wards with COVID-19
  • capable of completing online questionnaires
  • speak Danish sufficiently for a therapeutic dialogue
  • provide informed consent

Exclusion criteria

Exclusion Criteria:

  • suffering from a severe psychiatric disorder (such as schizophrenia) or in ongoing psychotherapeutic treatment for a psychiatric disorder (such as major depression generalized anxiety disorder or others), that cannot be paused
  • unable to complete verbal phone- or videoconferencing calls
  • unable to complete electronic questionnaires
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Tele-delivered psychological intervention

    Weekly tele-delivered psychological intervention

    Behavioral: Tele-delivered psychological intervention

Interventions

  • BehavioralTele-delivered psychological intervention

    The intervention consists of two (or one, if preferred by caregivers) weekly tele-sessions during the ICU stay, lasting up to 30 minutes, and two sessions in the month after discharge from or death in the ICU. Sessions will be conducted via phone-calls or video-conferencing. Therapists will 1) validate caregivers' subjective experience, 2) normalize and psychoeducate about emotional reactions, and 3) offer emotion regulation drawing on contemporary cognitive treatment packages of decentering, acceptance and emotion tolerance. Sessions for bereaved caregivers will include psycho-education about grief, assessment of risk for adverse outcomes and information about available support, if needed. The intervention will be performed based on an intervention manual. The content of the intervention will be continually adapted and tailored to the needs of the participating caregivers by involving all caregivers in co-creating the intervention trough brief post-session interviews.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Rate of consent among informed eligible participants

    Time frame: At inclusion

  2. Completion rate

    Rates of completion of intervention sessions among participants

    Time frame: During and post-intervention (1 month)

  3. Peri-traumatic distress inventory (negative emotions)

    Symptoms of peri-traumatic distress, min. score 0, max score 24, higher score corresponds to worse distress

    Time frame: Pre-post intervention (1 month after discharge/death)

  4. Impact of Events Scale (6 item)

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

    Time frame: 1 month post intervention

  5. Impact of Events Scale (6 item)

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

    Time frame: 6 months post intervention

  6. Impact of Events Scale (6 item)

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

    Time frame: 12/13 months post intervention

Secondary outcomes

  1. Prolonged Grief-13-scale

    Prolonged Grief, scored according to diagnostic criteria for prolonged grief disorder

    Time frame: 6 and 13 months

  2. PROMIS Depression (8 item scale)

    Symptoms of depression, min. score 8, max score 40, higher score corresponds to worse symptoms

    Time frame: Baseline to 1, 6, and 12/13 months

  3. PROMIS Anxiety (8 item scale)

    Symptoms of anxiety, min. score 8, max score 40, higher score corresponds to worse symptoms

    Time frame: Baseline to 1, 6, and 12/13 months

  4. Perceived Stress Scale (4 item)

    Perceived stress, min. score 0, max score 16, higher score corresponds to worse stress

    Time frame: Baseline to 1, 6, and 12/13 months

Other outcomes

  1. Short Penn State Worry Questionnaire (3 items)

    Worry, min. score 3, max score 15, higher score corresponds to greater worry

    Time frame: Baseline to 1, 6, and 12/13 months

  2. Brooding subscale of Ruminative Responses Scale

    Brooding, min. score 5, max score 20, higher score corresponds to greater brooding/rumination

    Time frame: Baseline to 1, 6, and 12/13 months

  3. Intolerance of uncertainty Scale (2 item)

    Intolerance of uncertainty, min score 2, max score 8, greater score indicates greater uncertainty intolerance

    Time frame: Baseline to 1, 6, and 12/13 months

07

Study locations

6 sites
  • Skejby Hospital
    Aarhus, Denmark
  • Rigshospitalet
    Copenhagen, 2100, Denmark
  • Hospitalsenheden Vest, Horsens
    Horsens, Denmark
  • Hvidovre Hospital
    Hvidovre, Denmark
  • Sygehus Lillebælt, Kolding
    Kolding, Denmark
  • Odense University Hospital
    Odense, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04409821
Lead sponsor
Rigshospitalet, Denmark
Responsible party
Annika von Heymann (Postdoc, Rigshospitalet, Denmark) — Principal investigator
First posted
Jun 1, 2020
Start date
May 29, 2020
Primary completion
May 31, 2022
Completion
May 31, 2022
Last update
Nov 18, 2023

Study contacts

Annika von Heymann, PhD
principal investigator · Department of Oncology, Rigshospitalet, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion